Clinical Trial Update: PhI to Solid Tumors and PhII to Locally Advanced or mTNBC [Phase 1]

View source ↗

Summary

Laekna Limited reports a Phase 1 trial in solid tumors and a Phase 2 trial in locally advanced or metastatic triple-negative breast cancer; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Laekna Limited | Conditions: Solid Tumor, TNBC - Triple-Negative Breast Cancer | Phase 1 | Status: COMPLETED